BIO-key International (NASDAQ:BKYI – Get Free Report) was upgraded by equities research analysts at Zacks Research to a “hold” rating in a research report issued on Thursday,Zacks.com reports.
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Reduce”.
Read Our Latest Research Report on BIO-key International
BIO-key International Stock Up 1.3%
Institutional Inflows and Outflows
A hedge fund recently raised its position in BIO-key International stock. Geode Capital Management LLC increased its stake in shares of BIO-key International Inc. (NASDAQ:BKYI – Free Report) by 49.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,892 shares of the technology company’s stock after buying an additional 16,271 shares during the quarter. Geode Capital Management LLC owned 0.45% of BIO-key International worth $26,000 at the end of the most recent quarter. 26.51% of the stock is currently owned by institutional investors and hedge funds.
BIO-key International Company Profile
BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.
In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.
Recommended Stories
- Five stocks we like better than BIO-key International
- MarketBeat Week in Review – 08/03 – 08/07
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with MarketBeat.com's FREE daily email newsletter.
